| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Orbital Therapeutics
Orbital Therapeutics is a biotechnology company that develops RNA-based medicine…
|
2025-10-10 | Acquisition | Pending | $1.5B | Deal โ |
| 2 |
2seventy bio
2seventy bio is an immuno-oncology cell therapy company that discovers and devel…
|
2025-03-10 | Merge | Complete | $286.0M | Deal โ |
| 3 |
RayzeBio
RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical…
|
2023-12-26 | Acquisition | Complete | — | Deal โ |
| 4 |
Karuna Therapeutics
Karuna Therapeutics is a biopharmaceutical company that develops and delivers me…
|
2023-12-22 | Merge | Complete | $14.0B | Deal โ |
| 5 |
Mirati Therapeutics
Mirati Therapeutics is a Biotechnology company located in 9363 Towne Centre Dr, …
|
2023-10-08 | Acquisition | Complete | $4.8B | Deal โ |
| 6 |
Turning Point Therapeutics
Turning Point Therapeutics is a pharmaceutical company that discovers and develo…
|
2022-06-03 | Acquisition | Complete | $4.1B | Deal โ |
| 7 |
MyoKardia
MyoKardia is a clinical-stage biopharmaceutical company that develops targeted t…
|
2020-10-05 | Acquisition | Complete | $13.1B | Deal โ |
| 8 |
Forbius
Forbius is a biopharmaceutical company that develops and designs niotherapeutics…
|
2020-08-24 | Acquisition | Complete | — | Deal โ |
| 9 |
Celgene
Celgene discovers, develops and commercializes innovative therapies to treat can…
|
2019-11-20 | Acquisition | Complete | — | Deal โ |
| 10 |
Celgene
Celgene discovers, develops and commercializes innovative therapies to treat can…
|
2019-01-03 | Acquisition | Complete | $74.0B | Deal โ |
| 11 |
IFM Therapeutics
DescriptionIFM Therapeutics is a pharmaceutical company focused on developing bi…
|
2017-08-03 | Acquisition | Complete | — | Deal โ |
| 12 |
Cormorant Pharmaceuticals
Cormorant Pharmaceuticals is a biopharmaceutical company.
|
2016-07-05 | Acquisition | Complete | — | Deal โ |
| 13 |
Padlock Therapeutics
Padlock is developing medicines targeting PADs, immune complexes in autoimmune d…
|
2016-03-23 | Acquisition | Complete | $600.0M | Deal โ |
| 14 |
Cardioxyl Pharmaceuticals
Cardioxyl Pharmaceuticals discovers, develops and commercializes therapies for t…
|
2015-11-02 | Acquisition | Complete | $2.0B | Deal โ |
| 15 |
Flexus Biosciences
Flexus is a privately-held biopharmaceutical company focused on the creation of …
|
2015-02-23 | Acquisition | Complete | $1.2B | Deal โ |
| 16 |
iPierian
iPierian is a drug discovery platform that develops therapies for neurodegenerat…
|
2014-04-29 | Acquisition | Complete | $725.0M | Deal โ |
| 17 |
Amylin Pharmaceuticals
Amylin Pharmaceuticals is a biopharmaceutical company, engages in the discovery,…
|
2012-07-01 | Acquisition | Complete | $5.3B | Deal โ |
| 18 |
Inhibitex
Inhibitex is a clinical-stage biopharmaceutical company that develops treatments…
|
2012-01-07 | Acquisition | Complete | $2.5B | Deal โ |
| 19 |
Amira Pharmaceuticals
Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the …
|
2011-07-21 | Acquisition | Complete | $475.0M | Deal โ |
| 20 |
ZymoGenetics
ZymoGenetics’ early focus on the development of production systems for recombina…
|
2010-09-08 | Acquisition | Complete | $885.0M | Deal โ |
| 21 |
Medarex
Medarex, Inc. discovers, develops, and commercializes human antibody-based thera…
|
2009-07-22 | Acquisition | Complete | $2.1B | Deal โ |
| 22 |
C
ConvaTec Divestiture
ConvaTec has been a pioneer in developing and marketing innovative wound therape…
|
2008-08-01 | Acquisition | Complete | — | Deal โ |
| 23 |
Kosan Biosciences
Kosan Biosciences is a cancer therapeutics company developing various classes of…
|
2008-05-29 | Acquisition | Complete | $190.0M | Deal โ |
| 24 |
Adnexus
Adnexus Therapeutics engages in the development of Adnectins biologics and medic…
|
2007-09-24 | Acquisition | Complete | $415.0M | Deal โ |
| 25 |
D
DuPont Pharmaceuticals
DuPont Pharmaceuticals engages in the research, development, and delivery of pha…
|
2001-10-02 | Acquisition | Complete | — | Deal โ |